准长非编码RNAMALAT1可保护内皮细胞的完整性,并防止纤维化
Qiao Zhao1, Loïs A K van der Pluijm1, Morgane Gourvest2
1Department of Internal Medicine (Nephrology) and the Einthoven Laboratory for Vascular and Regenerative Medicine, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
Molecular therapy. Nucleic acids
|September 22, 2025
概括
长非编码RNA Malat1 (转移相关的肺腺癌转录1) 在纤维化时升高,向它通过改善内皮细胞功能来保护纤维化.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 纤维化,慢性病的一个标志,涉及毛细血管网络损伤.
- 在纤维化期间,长非编码RNAs (lncRNAs) 在内皮细胞 (ECs) 中的作用尚不清楚.
研究的目的:
- 研究lncRNAs的作用,特别是Malat1 (转移相关的肺腺癌转录1),在纤维化期间的EC中.
- 探索Malat1作为纤维化的潜在治疗标.
主要方法:
- 对于损伤 (缺血-再输血和UUO) 的小鼠EC血统追踪模型.
- 在小鼠模型和人类纤维性病患者中分析马拉特1表达.
- 在UUO模型中针对马拉特1的药理干预.
- 转录基因分析,RNA免疫沉和分析.
主要成果:
- 马拉特1的表达在损伤期间和患有纤维性病的患者中在EC上升调节.
- 药理上抑制马拉特1减少了纤维化,原沉积和阿尔法平滑肌肉活性蛋白阳性细胞.
- 马拉特1抑制增加了毛细血管密度,减少了内皮细胞到介质细胞的过渡,改善了屏障功能和增强了血管反应.
- 马拉特1与PRC2复合体成员SUZ12相互作用,表明转录调节.
结论:
- lncRNA Malat1是EC功能和脏健康的关键调节者.
- 向Malat1是一个有前途的治疗策略,可以缓解纤维化.
关键词:
马拉特语 马拉特语MT:非编码RNAs的使用.对于RNA疗法来说,这是一种很好的方法.反感的寡核化物.慢性脏疾病 慢性脏疾病细胞内皮细胞的功能.脏纤维化 脏纤维化长长的非编码RNAs.血管完整性 血管完整性更多相关视频
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
1.9K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.8K
相关概念视频
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
